Hematologic Malignancy
Monoclonal B-Cell Lymphocytosis
CI-CAN-00006047MBLExplore in graph →
HematologicNon-malignant
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00006047MBLExplore in graph →
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02309515 | Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis | terminated | Phase 2 | 12 | Mayo ClinicOTHER | 1 | Jan 19, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Jan 19, 2021source: clinicaltrials